“Regulatory considerations for emergency use authorizations of medical products U/s 564 of the federal food drug and cosmetic act, usa”, World Journal of Current Med and Pharm Research, vol. 3, no. 5, pp. 116–119, Oct. 2021, doi: 10.37022/wjcmpr.v3i5.192.